BD announces first pharma-sponsored clinical trial using BD Libertas wearable injector technology for biologic drugs Read more
Sun Pharma’s phase 3 clinical studies evaluating ILUMYA in active psoriatic arthritis met their primary endpoint Read more
Auriga Research, SFRI sign MoU to build AI-integrated, globally compliant healthcare ecosystem Read more
IGI reports phase 1 results of ISB 2001 trispecific antibody in relapsed or refractory multiple myeloma Read more
Vgenomics, Dr. Shroff Charity Eye Hospital partner to validate biomarker for early Keratoconus detection Read more
Lupin announces presentation of phase 1 data on LNP7457 (PRMT5 inhibitor) at the ASCO – Annual Meeting 2025 Read more